Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
Mycoses ; 59(5): 281-90, 2016 May.
Article in English | MEDLINE | ID: mdl-26864989

ABSTRACT

This study aimed to investigate the influence of tetraconazole and malathion, both used in agricultural activities, on resistance to fluconazole, itraconazole and voriconazole in Candida parapsilosis ATCC 22019. The susceptibility to tetraconazole, malathion, fluconazole, itraconazole and voriconazole, through broth microdilution. Then, 12 independent replicates, were separated and exposed to four treatment groups, each one containing three replicates: G1: tetraconazole; G2: malathion; G3: fluconazole (positive control); G4: negative control. Replicates from G1, G2 and G3, were exposed to weekly increasing concentrations of tetraconazole, malathion and fluconazole, respectively, ranging from MIC/2 to 32 × MIC, throughout 7 weeks. The exposure to tetraconazole, but not malathion, decreased susceptibility to clinical azoles, especially fluconazole. The tetraconazole-induced fluconazole resistance is partially mediated by the increased activity of ATP-dependent efflux pumps, considering the increase in antifungal susceptibility after the addition of the efflux pump inhibitor, promethazine, and the increase in rhodamine 6G efflux and CDR gene expression in the G1 replicates. Moreover, MDR expression was only detected in G1 and G3 replicates, suggesting that MDR pumps are also involved in tetraconazole-induced fluconazole resistance. It is noteworthy that tetraconazole and fluconazole-treated replicates behaved similarly, therefore, resistance to azoles of clinical use may be a consequence of using azoles in farming activities.


Subject(s)
Antifungal Agents/pharmacology , Candida/drug effects , Chlorobenzenes/pharmacology , Fluconazole/pharmacology , Fungicides, Industrial/pharmacology , Triazoles/pharmacology , ATP-Binding Cassette Transporters/antagonists & inhibitors , ATP-Binding Cassette Transporters/genetics , ATP-Binding Cassette Transporters/metabolism , Animals , Anti-Allergic Agents/pharmacology , Candida/genetics , Drug Resistance, Microbial , Ergosterol/analysis , Gene Expression Regulation, Fungal , Humans , Itraconazole/pharmacology , Malathion/pharmacology , Microbial Sensitivity Tests , Promethazine/pharmacology , Rhodamines , Sterol 14-Demethylase/genetics , Voriconazole/pharmacology
2.
J Appl Microbiol ; 120(3): 600-6, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26669506

ABSTRACT

AIMS: The aim of this study was to analyse the in vitro activity of farnesol alone and combined with the antibacterial drugs amoxicillin, doxycycline, ceftazidime and sulfamethoxazole-trimethoprim against Burkholderia pseudomallei biofilms. METHODS AND RESULTS: Susceptibility was assessed by the broth microdilution test and cell viability was read with the oxidation-reduction indicator dye resazurin. The biofilms were evaluated through three microscopic techniques (optical, confocal and electronic microscopy). The minimum biofilm erradication concentration (MBEC) for farnesol was 75-2400 mmol l(-1). In addition, farnesol significantly reduced the MBEC values for ceftazidime, amoxicillin, doxycycline and sulfamethoxazole-trimethoprim by 256, 16, 4 and 4 times respectively (P < 0·05). Optical, confocal and electronic microscopic analyses of farnesol-treated B. pseudomallei biofilms demonstrated that this compound damages biofilm matrix, probably facilitating antimicrobial penetration in the biofilm structure. CONCLUSIONS: This study demonstrated the effectiveness of farnesol against B. pseudomallei biofilms and its potentiating effect on the activity of antibacterial drugs, in particular ceftazidime, amoxicillin, doxycycline and sulfamethoxazole-trimethoprim. SIGNIFICANCE AND IMPACT OF THE STUDY: The intrinsic antimicrobial resistance of B. pseudomallei is a serious challenge for the treatment of melioidosis. Thus, this paper reports the inhibitory potential of farnesol against B. pseudomallei biofilms, as well as highlights the favourable pharmacological interaction of farnesol with antibiotics tested, not only on cell viability, but also in the structural morphology of biofilms.


Subject(s)
Biofilms/drug effects , Burkholderia pseudomallei/drug effects , Farnesol/pharmacology , Melioidosis/microbiology , Amoxicillin/pharmacology , Anti-Bacterial Agents/pharmacology , Burkholderia pseudomallei/physiology , Ceftazidime/pharmacology , Humans , Melioidosis/drug therapy , Microbial Sensitivity Tests/methods , Trimethoprim, Sulfamethoxazole Drug Combination
3.
Mycopathologia ; 180(3-4): 277-80, 2015 Oct.
Article in English | MEDLINE | ID: mdl-25898770

ABSTRACT

Small ruminant production is a common agricultural activity worldwide. However, studies on the fungal microbiota of these animals are scarce. Therefore, this study aimed at isolating yeasts from goats and sheep and evaluating the antifungal susceptibility of the recovered Candida albicans. A total of 120 animals from farms in Ceará State, Brazil, were assessed in this study. The samples were collected from nasal, oral and rectal cavities with sterile swabs. Candida spp., Trichosporon spp. and Rhodotorula spp. were isolated from small ruminants. Resistance to three azole drugs was observed in C. albicans. In summary, Candida spp. were predominantly observed as part of the microbiota of the nasal, oral and rectal cavities of small ruminants, including azole-resistant strains of C. albicans.


Subject(s)
Antifungal Agents/pharmacology , Azoles/pharmacology , Candida albicans/isolation & purification , Drug Resistance, Fungal , Goats/microbiology , Sheep/microbiology , Animals , Brazil , Mouth/microbiology , Nasal Cavity/microbiology , Rectum/microbiology , Rhodotorula/isolation & purification , Trichosporon/isolation & purification
4.
Antimicrob Agents Chemother ; 56(4): 2198-200, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22290941

ABSTRACT

This study aimed to evaluate the in vitro combination of farnesol and ß-lactams against Burkholderia pseudomallei. A total of 12 ß-lactamase-positive strains were tested according to CLSI standards. All strains were inhibited by farnesol, with MICs ranging from 75 to 150 µM. The combination of this compound with ß-lactams resulted in statistically significant ß-lactam MIC reduction (P ≤ 0.05). This study provides new perspectives for the use of farnesol combined with ß-lactam antibiotics against strains of B. pseudomallei.


Subject(s)
Anti-Bacterial Agents/pharmacology , Burkholderia pseudomallei/drug effects , Farnesol/pharmacology , beta-Lactams/pharmacology , Burkholderia pseudomallei/growth & development , Drug Resistance, Bacterial , Drug Synergism , Microbial Sensitivity Tests , beta-Lactamases/metabolism
5.
Clin Microbiol Infect ; 17(5): 719-21, 2011 May.
Article in English | MEDLINE | ID: mdl-21521412

ABSTRACT

Melioidosis, a severe infectious disease caused by Burkholderia pseudomallei that is prevalent in Southeast Asia and Northern Australia, has been sporadically reported in Brazil since 2003. We report a case of aortic aneurysm with blood culture positive for B. pseudomallei. The phylogenetic analysis of 16S ribosomal DNA showed this isolate to be evolutionarily grouped with the MSHR346 strains from Thailand.


Subject(s)
Aneurysm, Infected/microbiology , Burkholderia pseudomallei/genetics , Burkholderia pseudomallei/isolation & purification , Melioidosis/microbiology , Aged , Brazil , Humans , Male , Melioidosis/mortality , Phylogeny , RNA, Ribosomal, 16S/genetics , Thailand
SELECTION OF CITATIONS
SEARCH DETAIL